Compare Fiverr International Ltd (FVRR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs BIO-TECHNE Corp — how do they compare? Fiverr International Ltd trades at $8.69 (market cap $310.61M), while BIO-TECHNE Corp trades at $72.45 (market cap $11.36B). The key difference: BIO-TECHNE Corp is far larger — about 36.6× Fiverr International Ltd's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and BIO-TECHNE Corp for 63 Days on average.
| FVRR | TECH | |
|---|---|---|
Market Cap | $310.61M | $11.36B |
Volume | 381,459 | 5,390,331 |
Sector | Media | Health |
52-Week High | $23.60 | $72.61 |
52-Week Low | $8.47 | $43.31 |
Typical Hold Time | 62 Days | 63 Days |
Enterprise Value | $63.00M | $11.39B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.68, up 2.12% with bearish technical signals despite attractive valuation metrics including a P/E of 10.67 and P/S of 0.76. Recent earnings show mixed results with Q2 2026 missing estimates, while revenue growth has slowed from 2025's $431M to projected $418M in 2026. The company faces AI disruption pressures but maintains strong gross margins of 82% and positive net income.
The outlook remains cautious with analysts predominantly holding neutral ratings (76% Hold) and a $10.50 price target suggesting modest upside. Key risks include AI competition compressing freelance demand, while potential exists if Fiverr successfully adapts its platform to AI-driven market changes. Current valuation appears reasonable for patient investors despite near-term headwinds.
Bio-Techne (TECH) trades at $72.45, down 0.11% on the day, near its 52-week high of $72.70. The stock shows bullish technical signals with strong moving average support. Fundamentally, the company maintains solid gross margins of 65.77% but faces declining net income margins, dropping from 24.6% in 2022 to 6.01% in 2025. Recent shareholder approval of Merck KGaA's acquisition at $73 per share provides a clear near-term catalyst.
The pending acquisition offers limited upside from current levels but provides downside protection. However, declining profitability trends and elevated valuation ratios (P/E 62.46) pose risks if the deal falls through. Investors should weigh the acquisition premium against fundamental deterioration in earnings quality.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
